PHENYLEPHRINE HCL injection solution

Country: Ամերիկայի Միացյալ Նահանգներ

language: անգլերեն

source: NLM (National Library of Medicine)

buyitnow

SPC SPC (SPC)
04-11-2017

active_ingredient:

Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV)

MAH:

Cantrell Drug Company

INN:

Phenylephrine Hydrochloride

composition:

Phenylephrine Hydrochloride 0.08 mg in 1 mL

prescription_type:

PRESCRIPTION DRUG

authorization_status:

unapproved drug other

SPC

                                PHENYLEPHRINE HCL - PHENYLEPHRINE HCL INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
PHENYLEPHRINE HCL 80 MCG/ML IN 0.9% SODIUM CHLORIDE 10 ML SYRINGE
PHENYLEPHRINE HCL
phenylephrine hcl injection, solution
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:52533-0 6 0
ROUTE OF ADMINISTRATION
INTRAVENOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PHENYLEPHRINE HYDRO CHLO RIDE (UNII: 0 4JA59 TNSJ) (Phenylephrine -
UNII:1WS29 7W6 MV)
Phe nyle phrine
Hydro c hlo ride
0 .0 8 mg
in 1 mL
Cantrell Drug Company
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO DIUM CHLO RIDE (UNII: 451W47IQ8 X)
9 mg in 1 mL
WA TER (UNII: 0 59 QF0 KO0 R)
SO DIUM METABISULFITE (UNII: 4VON5FNS3C)
0 .0 16 mg in 1 mL
SO DIUM CITRATE (UNII: 1Q73Q2JULR)
0 .0 32 mg in 1 mL
ANHYDRO US CITRIC ACID (UNII: XF417D3PSL)
0 .0 72 ug in 1 mL
OTHER INGREDIENTS
INGREDIENT KIND
INGREDIENT NAME
QUANTITY
May co ntain
SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:52533-0 6 0 -12
10 mL in 1 SYRINGE, PLASTIC
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 8 /30 /20 12
LABELER -
Cantrell Drug Company (035545763)
Revised: 12/2014
                                
                                read_full_document